PodParley PodParley
PodParley
LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib + Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma - report from ESMO2024 episode artwork

EPISODE · Oct 11, 2024 · 5 MIN

LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib + Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma - report from ESMO2024

from Medical Digest & Congress Report · host Medical Congress News

Professor Josep Llovet discusses the results of LEAP-012 Study which he presented at ESMO 2024. Video: https://medicaldigest.org/scientific-contents/interview:leap-012-study-transarterial-chemoembolization-or-without-lenvatinib-pembrolizumab-intermediate-stage-hepatocellular-carcinoma

Episode metadata supplied by the publisher feed · Published Oct 11, 2024

Embed this episode

NOW PLAYING

LEAP-012 Study: Transarterial Chemoembolization With or Without Lenvatinib + Pembrolizumab for Intermediate-Stage Hepatocellular Carcinoma - report from ESMO2024

0:00 5:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 5 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on October 11, 2024.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!